Administration of IL-10 to treat autoimmune diseases has been studied extensively and led to a reduction of psoriatic plaques in psoriasis and ameliorated the disease activity in intestinal bowel disease [27, 42]. This evidence concerns the gene IL10 and autoimmune disease.